S&P ASX All Technology

3,102.60

0.47%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Mei Pharma, Inc. (MM) (MSHL)
Mei Pharma, Inc. (MM) (MSHL) News

MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
10/07/2012	04:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
06/07/2012	06:03	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
03/07/2012	05:18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/06/2012	23:00	PR Newswire (US)	Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
06/06/2012	20:04	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
06/06/2012	07:28	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
04/06/2012	23:00	PR Newswire (US)	Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/05/2012	23:00	PR Newswire (US)	Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
26/05/2012	03:32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
16/05/2012	05:27	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
16/05/2012	03:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
16/05/2012	03:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
16/05/2012	03:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
16/05/2012	00:05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
14/05/2012	23:00	PR Newswire (US)	Marshall Edwards Completes Rights Offering To Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
08/05/2012	23:00	PR Newswire (US)	Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
25/04/2012	23:00	PR Newswire (US)	Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
14/04/2012	05:59	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
12/04/2012	04:41	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
10/04/2012	23:00	PR Newswire (US)	Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
03/04/2012	23:00	PR Newswire (US)	Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
31/03/2012	03:34	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
31/03/2012	03:32	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/03/2012	00:00	PR Newswire (US)	Marshall Edwards CEO to Present at Needham Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/03/2012	00:00	PR Newswire (US)	Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	21:02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	07:40	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
20/03/2012	23:55	Edgar (US Regulatory)	Securities Registration Statement (S-1/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
20/03/2012	00:00	PR Newswire (US)	Marshall Edwards Announces Terms for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
08/03/2012	04:17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)